Erythromycin base tablets

Details Erythromycin base tablets Erythromycin base tablets

A - Human Necessities

61

K

167/169, 167/187

A61K 9/36 (2006.01) A61K 9/28 (2006.01)

Patent

CA 1172167

Abstract of the Disclosure An enteric coated erythromycin tablet is pro- vided that produces essentially the same blood levels in fasting and nonfasting subjects. The tablet contains erythromycin base dihydrate and a highly water-soluble nontoxic salt in the core and the coating polymer is a hydroxypropyl methylcellulose phthalate.

390005

Affiliated with

Also associated with

Rating

Erythromycin base tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythromycin base tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythromycin base tablets will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1211221